• Title/Summary/Keyword: Solid inhibitors

Search Result 48, Processing Time 0.023 seconds

Inhibitory Effect of Solid Inhibitors on LPG Combustible Mixtures (LPG 가연성 혼합물에 대한 고형 금지제의 억제 효과)

  • Hamdan, M. A.;Yamin, J. A.;Dabbas, R. K.
    • Journal of the Korean Chemical Society
    • /
    • v.54 no.3
    • /
    • pp.295-299
    • /
    • 2010
  • An experimental rig was constructed in order to study the inhibitory effects of two thermal inhibitors namely; stone and calcium carbonate, on Liquefied Petroleum Gas -air flames. This was achieved by measuring the flammability limits of the combustible mixtures before and after the addition of these inhibitors. It was found that calcium carbonate has superior inhibitory effect on the combustible mixture under investigation while, Stone has a lower inhibitory effect than that of calcium carbonate.

1-Benzyl indazole derivative-based 18F-labeled PET radiotracer: Radiosynthesis and cell uptake study in cancer cells

  • More, Kunal N.;Lee, Jun Young;Park, Jeong-Hoon;Chang, Dong-Jo
    • Journal of Radiopharmaceuticals and Molecular Probes
    • /
    • v.5 no.1
    • /
    • pp.36-47
    • /
    • 2019
  • Hypoxia-inducible factor-1 ($HIF-1{\alpha}$) is a transcription factor activated in response to low oxygen level, and is highly expressed in many solid tumors. Moreover, $HIF-1{\alpha}$ is a representative biomarker of hypoxia and also helps to maintain cell homeostasis under hypoxic condition. Most solid tumors show hypoxia, which induces poor prognosis and resistance to conventional cancer therapies. Thus, early diagnosis of hypoxia with positron emission tomography (PET) radiotracer would be highly beneficial for management of malignant solid tumors with effective cancer therapy. YC-1 is a most promising candidate among several $HIF-1{\alpha}$ inhibitors. As an effort to develop a hypoxia imaging tool as a PET radiotracer, we designed and synthesized [$^{18}F$]DFYC based on potent derivative of YC-1 and performed preliminary in vitro cell uptake study. [$^{18}F$]DFYC showed a significant accumulation in SKBR-3 cells among other cancer cells, proving as a good lead to develop a hypoxic solid tumor such as breast cancer.

Large Eddy Simulation on Inhibitor Effect of a Large Solid Rocket Motor (대형 고체로켓의 그레인간 인히비터에 의한 유동 교란 특성 LES)

  • Hong, Ji-Seok;Heo, Jun-Young;Moon, Hee-Jang;Sung, Hong-Gye;Lee, Do-Hyung;Kim, Yoon-Gon
    • Proceedings of the Korean Society of Propulsion Engineers Conference
    • /
    • 2011.11a
    • /
    • pp.31-37
    • /
    • 2011
  • Detail flow structure in a large solid rocket motor with two inhibitors has been investigated using 3D Large Eddy Simulation and Proper Orthogonal Decomposition(POD) analysis. Vortex shedding frequencies periodically occurred by inhibitors are coupled with flow acoustics induced by the impinging of vorticity on nozzle head. As a result of 3D analysis, it was observed that the nozzle exit flow causes roll-torques from the vortex being decomposed in unbalanced shape for the impinging of vorticity on the nozzle head.

  • PDF

Novel Inhibitors of Prolyl 4-Hydroxylase; Solid-phase Synthesis of 2,2-Dimethyl-3,4-Dialkoxy-Substituted 6-Aminobenzopyran Derivatives

  • Seo, Jin-soo;Joo, Yang-Hee;Yi, Jung-Bum;Lee, Eun-Ju;Lee, Nam-Kyu;Cho, Yong-Balk;Kwak, Wie-Jong;Hwang, Jong-Yeon;Jeon, Yong-Seog;Jeon, Hyun-Suk;Yoo, Sung-eun;Yoon, Cheol-Min;Dong, Mi-Sook;Gong, Young-Dae
    • Bulletin of the Korean Chemical Society
    • /
    • v.27 no.6
    • /
    • pp.909-917
    • /
    • 2006
  • 2,2-Dimethyl-3,4-dialkoxy-substituted 6-aminobenzopyran analogues (eg., 7 and 8) were identified as prolyl 4-hydroxylase inhibitors via a screening process using HSC-T6 and LI 90 cells that express an immortalized rat hepatic stellate cell line and as part of a test of the type I collagen contents employing the ELISA method. A subsequent lead optimization effort based on solid-phase parallel synthesis led to the identification of 2,2-dimethyl-3,4-dialkoxy-substituted 6-aminobenzopyrans as potent inhibitors of prolyl 4-hydroxylase.

The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis

  • You, Weon-Kyoo;McDonald, Donald M.
    • BMB Reports
    • /
    • v.41 no.12
    • /
    • pp.833-839
    • /
    • 2008
  • Angiogenesis in tumors is driven by multiple growth factors that activate receptor tyrosine kinases. An important driving force of angiogenesis in solid tumors is signaling through vascular endothelial growth factor (VEGF) and its receptors (VEGFRs). Angiogenesis inhibitors that target this signaling pathway are now in widespread use for the treatment of cancer. However, when used alone, inhibitors of VEGF/VEGFR signaling do not destroy all blood vessels in tumors and do not slow the growth of most human cancers. VEGF/VEGFR signaling inhibitors are, therefore, used in combination with chemotherapeutic agents or radiation therapy. Additional targets for inhibiting angiogenesis would be useful for more efficacious treatment of cancer. One promising target is the signaling pathway of hepatocyte growth factor (HGF) and its receptor (HGFR, also known as c-Met), which plays important roles in angiogenesis and tumor growth. Inhibitors of this signaling pathway have been shown to inhibit angiogenesis in multiple in vitro and in vivo models. The HGF/c-Met signaling pathway is now recognized as a promising target in cancer by inhibiting angiogenesis, tumor growth, invasion, and metastasis.

Current Status of Immunotherapy for Lung Cancer and Future Perspectives

  • Kim, Ho Cheol;Choi, Chang-Min
    • Tuberculosis and Respiratory Diseases
    • /
    • v.83 no.1
    • /
    • pp.14-19
    • /
    • 2020
  • Lung cancer remains the most common cause of cancer-related deaths worldwide. Although there are many possible treatments, including targeted therapies such as epidermal growth factor receptor tyrosine kinase inhibitors and anaplastic lymphoma kinase inhibitors, new therapeutic strategies are needed to improve clinical outcomes. Immunotherapy through the use of immune checkpoint inhibitors has provided one of the most important breakthroughs in the management of solid tumors, including lung cancers, and has shown promising results in numerous clinical trials. This review will present the current status of immunotherapy for lung cancer and future perspectives on these treatments.

Effects of Protein Kinase Inhibitors on In Vitro Protein Phosphorylation and on Secondary Metabolism and Morphogenesis in Streptomyces coelicolor A3(2)

  • Hong, Soon-Kwang;Sueharu, Horinouchi
    • Journal of Microbiology and Biotechnology
    • /
    • v.8 no.4
    • /
    • pp.325-332
    • /
    • 1998
  • In vitro phosphorylation experiments with a cell extract of Streptomyces coelicolor A3(2) M130 in the presence of ${\gamma}-[^32P]$]ATP revealed the presence of multiple phosphorylated proteins, including the AfsR/AfsK kinases which control the biosynthesis of A-factor, actinorhodin, and undecylprodigiosin. Phosphorylation of AfsR by a cell extract as an AfsK source was significantly inhibited by Ser/Thr protein kinase inhibitors, staurosporine and K-252a, at concentrations giving 50% inhibition ($IC_50$) of $1{\mu}M\;and\;0.1{\mu}M$, respectively. Further in vitro experiments with the cell extracts showed that phosphorylation of multiple proteins was inhibited by various protein kinase inhibitors with different inhibitory profiles. Manganese and calcium ions in the reaction mixture also modulate phosphorylation of multiple proteins. Manganese at 10 mM greatly enhanced the phosphorylation and partially circumvented the inhibition caused by staurosporine and K-252a. A calcium-activated protein kinase(s) was little affected by these inhibitors. Herbimycin and radicicol, which are known as tyrosine kinase inhibitors, did not show any significant inhibition of AfsR phosphorylation. Consistent with the in vitro effect of the kinase inhibitors, they inhibited aerial mycelium formation and pigmented antibiotic production on solid media. On the contrary, when assayed in liquid culture, the amount of actinorhodin produced was increased by staurosporine and K-252a and greatly decreased by manganese. All of these data clearly show that the genus Streptomyces possesses several protein kinases of eukaryotic types which are involved in the regulatory network for morphogenesis and secondary metabolism.

  • PDF

3D-QSAR Study on Imidazopyridazines Derivatives as Potent Pim-1 Kinase Inhibitors using Region-Focused CoMFA

  • Balasubramanian, Pavithra K.;Balupuri, Anand;Cho, Seung Joo
    • Journal of Integrative Natural Science
    • /
    • v.10 no.2
    • /
    • pp.95-104
    • /
    • 2017
  • Proviral Integration site of Moloney (Pim) murine Leukemia virus kinases is a serine/threonine specific protein kinase. It is largely involved in cell survival and proliferation. Pim-1 phosphorylates multiple cellular substrates to inhibit apoptosis and promote cell cycle progression. Over expression of Pim-1 kinase is observed in a range of malignancies and various solid cancers. High level of Pim-1 expression is seen in myeloma, acute myeloid leukemia, prostate cancer and liver carcinomas. Hence, Pim-1 is considered as an interesting cancer target. In the present study, we have performed region-focused CoMFA study on a series of imidazopyridazine derivatives as Pim-1 kinase inhibitors. A statistically acceptable region-focused CoMFA model ($q^2=0.571$; ONC=3; $r^2=0.909$) was developed. The model was then validated using Bootsrapping and progressive sampling. The contour map highlighted the regions favorable to increase the activity. Bulky substitutions in $R^2$ position of the phenyl ring could increase the activity. Similarly, small negative substitution in the $R^1$ position of the Pyridine ring could increase the activity considerably. Our results will be useful to design novel Pim-1 kinase inhibitors of this series.

Angiogenesis Inhibitor Derived from Angiostatin Active Sites

  • Park, Kyoung-Soo;Lim, Dong-Yeol;Park, Sang-Don;Kim, Min-Young;Kim, Yang-Mee
    • Bulletin of the Korean Chemical Society
    • /
    • v.25 no.9
    • /
    • pp.1331-1335
    • /
    • 2004
  • Angiogenesis is essential for the growth and persistence of solid tumors. Their metastases, anti-angiogenesis could lead to the suppression of tumor growth. One of the main strategies of cancer treatment is developing molecules of anti-angiogenic activity. In this study, two angiogenic inhibitors, Ang3 (KLFDF) and Ang4 (XLFDF) derived from KLYDY, which is the sequence of angiostatin active sites kringle 5, were designed and synthesized. Previously we reported the activities and structures of two inhibitors, Ang1 (KLYDY) and Ang2 (KLWDF). In order to investigate the effect of Phe substitution, Ang3 was designed with a sequence of KLFDF. In order to reduce conformational flexibility of side chain in Lys, Ang4 was designed with a sequence of XLFDF, where X has amino substituted phenyl ring. Solution structures of those inhibitors were investigated using NMR spectroscopy and their activities as angiogenesis inhibitors were studied. Ang1 and Ang2 show angiogenic activities, while Ang3 and Ang4 have no activities and have extended structures compared to Ang1 and Ang2. Therefore, Phe rings do not have effective hydrophobic interactions with other aromatic residues in Ang3 and Ang4. The representative structure of Ang2 has a stable intramolecular hydrogen bond. Therefore, intramolecular hydrogen bonding might be more important in stabilizing the structure than the hydrophobic interactions in these inhibitors. More rigid structure, which can be expected to have higher activities and better match with the receptor bound conformations, can be obtained with a constrained cyclic structure. Further peptidomimetic approaches should be tried to develop angiogenesis inhibitors.